Search results
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 5.8%
ETF DAILY NEWS· 3 days agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) shares were up 5.8% during trading on Wednesday . The company traded as high as $31.59 and last traded at $31.59. Approximately ...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 3 days agoIn the past six months, shares of MRNA have rallied 108.94%. (See the last biotech stock roundup...
The WHO’s failure to reach a pandemic agreement underscores a global health divide
Semafor via Yahoo News· 11 hours agoNegotiations stalled over disagreements related to intellectual property and access. Now, the World...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 3 days agoNasdaq Biotechnology Index has moved up 0.83% in the past five trading sessions and Moderna's shares...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Benzinga via Yahoo Finance· 6 days agoTuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks via Yahoo Finance· 4 days agoImage Source: Zacks Investment Research Descartes-08 is an autologous anti-B cell maturation antigen...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks· 4 days agoWith the end of the first-quarter earnings season, the focus has now shifted to pipeline and regulatory updates. Mergers and acquisitions continue to be in the spotlight as pharma and biotech ...
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update
Digital Journal· 7 days agoTORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 3 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 7 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more than 90 percent in persons at risk of severe...